Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alf Spitschak

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Theranostics|February 22, 2018
MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistanceXin Lai, Shailendra K Gupta, Ulf Schmitz, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 10, 2019
Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasivenessChristin Richter, Stephan Marquardt, Fanghua Li, et al.
The Journal of Urology|February 21, 2016
Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient OutcomeJuliane M Hartz, David Engelmann, Katharina Fürst, et al.
International Journal of Cancer|November 1, 2015
Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantationRosaely Casalegno-Garduño, Anita Schmitt, Alf Spitschak, et al.
The Journal of Pathology|July 22, 2014
Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectinClaudia Meier, Alf Spitschak, Kerstin Abshagen, et al.
Nature Communications|August 5, 2017
Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signaturesFaiz M Khan, Stephan Marquardt, Shailendra K Gupta, et al.
Cancer Letters|June 12, 2025
TAp73α drives cancer metastasis via PPI-mediated derepression of the neuronal HDAC2/REST-GABBR2 axisNico Murr, Christin Richter, Shailendra K Gupta, et al.
Frontiers in Immunology|November 15, 2024
E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsivenessAlf Spitschak, Prabir Dhar, Krishna P Singh, et al.
Journal of Molecular Cell Biology|September 10, 2013
E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-BDavid Engelmann, Deborah Mayoli-Nüssle, Christian Mayrhofer, et al.
Cancer Letters|November 17, 2018
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progressionKatharina Fürst, Marc Steder, Stella Logotheti, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Theranostics|February 22, 2018
MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistanceXin Lai, Shailendra K Gupta, Ulf Schmitz, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 10, 2019
Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasivenessChristin Richter, Stephan Marquardt, Fanghua Li, et al.
The Journal of Urology|February 21, 2016
Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient OutcomeJuliane M Hartz, David Engelmann, Katharina Fürst, et al.
International Journal of Cancer|November 1, 2015
Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantationRosaely Casalegno-Garduño, Anita Schmitt, Alf Spitschak, et al.
The Journal of Pathology|July 22, 2014
Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectinClaudia Meier, Alf Spitschak, Kerstin Abshagen, et al.
Nature Communications|August 5, 2017
Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signaturesFaiz M Khan, Stephan Marquardt, Shailendra K Gupta, et al.
Cancer Letters|June 12, 2025
TAp73α drives cancer metastasis via PPI-mediated derepression of the neuronal HDAC2/REST-GABBR2 axisNico Murr, Christin Richter, Shailendra K Gupta, et al.
Frontiers in Immunology|November 15, 2024
E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsivenessAlf Spitschak, Prabir Dhar, Krishna P Singh, et al.
Journal of Molecular Cell Biology|September 10, 2013
E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-BDavid Engelmann, Deborah Mayoli-Nüssle, Christian Mayrhofer, et al.
Cancer Letters|November 17, 2018
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progressionKatharina Fürst, Marc Steder, Stella Logotheti, et al.
Pageof 3